Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Ombrabulin

EU orphan designation number: EU/3/11/853
Active ingredient: Ombrabulin
Indication: Treatment of soft tissue sarcoma
Sponsor: Sanofi-Aventis groupe
54 rue La Boétie, F-75008 Paris, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/04/2011 Orphan designation EMA/OD/141/10 (2011)2840 of 15/04/2011
06/11/2012 Change of name and/or address of sponsor EMA/OD/141/10
23/04/2014 Removal of orphan designation from Community Register